Girls with laron syndrome having positive growth hormone binding protein (GHBP) are less retarded in height than those lacking GHBP

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 3, 1997, Pages 305-307

  Laron, Zvi ^a,c   Desai, Meena ^b   Silbergeld, Aviva ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Sir Hurkinsondas Nurrotumdas Med R   (India)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; SOMATOMEDIN C;

CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; HUMAN; MALE;

EID: 0030918437     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1997.10.3.305     Document Type: Conference Paper

References (14)

1. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987; 330: 537-543.
2. Dastot F, Sobrier M-L, Duquesnoy P, Duriez B, Goosens M, Amselem S. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulates its ability to generate a soluble GH-binding protein. Proc Natl Acad Sci USA 1996; 93: 10723-10728.
3. Baumann G. Editorial: growth hormone binding protein - errant receptor or active player? Endocrinology 1995; 136: 377-378.
4. Laron Z, Blum W, Chatelain P, Ranke M, Rosenfeld R, Savage MO, Underwood L. Classification of growth hormone insensitivity syndrome. J Pediatr 1993; 122: 241.
5. Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab 1995; 80: 1526-1531.
6. Amselem S, Sobrier M-L, Dastot F, Duquesnoy P, Duriez B, Goosens M. Molecular basis of inherited growth hormone resistance in childhood. In: Ross RJM, Savage MO, eds. Growth Hormone Resistance. Bailliere's Clin Endocrinol Metab 1996; 10: 353-369.
7. Silbergeld A, Keret R,Selman-Almonte A, Klinger B, Laron Z. Serum growth hormone binding protein in Laron syndrome patients and their relatives. In: Laron Z, Parks JS, eds. Lessons from Laron Syndrome (LS) 1966-1992. A model of GH and IGF-I action and interaction. Basel: Karger. Pediatr Adolesc Endocrinol 1993; 24: 153-159.
8. Maheshwari HG, Clayton PE, Mughal Z, Price DA, Norman M. Laron-type dwarfism: the GHBP-positive phenotype. In: Laron Z, Parks JS, eds. Lessons from Laron Syndrome (LS) 1966-1992. A model of GH and IGF-I action and interaction. Basel: Karger. Pediatr Adolesc Endocrinol 1993; 24: 160-166.
9. Savage MO, Carlsson L, Chatelain PG, Ranke MB, Rosenfeld RG. Growth hormone insensitivity syndromes. Acta Paediatr 1995; 411 (Suppl): 87-90.
10. Woods KA, Neil FC, Postel-Vinay MC, Savage MO, Clark AJL. A homozygous splice mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab 1996; 81:1686-1690.
11. Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci 1993; 29: 757-763.
12. Silbergeld A, Dastot F, Klinger B, Kanety H, Eshet R, Amselem S, Laron Z. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree. J Pediatr Endocrinol Metab 1997;10: 265-274.
13. Rosenbloom AL, Aguirre JG, Rosenfeld RG, Fielder PJ. The little women of Loja - growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med 1990; 323: 1367-1374.
14. Woods KA, Savage MO. Laron syndrome: typical and atypical forms. In: Ross RJM, Savage MO, eds. Growth Hormone Resistance. Bailliere's Clin Endocrinol Metab 1996; 10: 371-387.